About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
An Under the Radar Electric Vehicle Stock Rated ‘Strong Buy’
Eaton (ETN) hasn’t received much attention amid the excessive hype surrounding electric vehicles (EVs), but it has been growing organically and inorganically for years. As EV market growth gains pace, the demand for the company’s products and services is expected to increase. So, it could be wise to bet on this under-the-radar stock now.
Navient is a Great Value Stock: Should You Buy?
Navient’s (NAVI) business was hit severely by the COVID-19 pandemic last year. But it has been consistently improving its performance on all fronts since, which is reflected in its increasing share price. As the economy gradually reopens and lending conditions for student loans improve, NAVI is expected to generate even better returns. So, we think now is an ideal time to bet on this undervalued stock.
Is Now the Time to Buy Tenable Holdings?
Shares of Tenable Holdings (TENB) have gained markedly over the past year as the demand for cybersecurity solutions accelerated due to a perceived growing threat posed by cyber hackers to organizations’ digital operations. Because this demand is likely to be sustained at least over in the near term, we think TENB’s stock appears to have plenty of upside. Let’s discuss.
Should You Buy the Dip in Bloom Energy?
Bloom Energy (BE) delivered stellar returns last year, but it has been on a downtrend lately. The fourth-quarter loss reported by the company is one of the factors that led to the pullback. But let’s find out if the hype around renewable energy can help BE achieve new all-time highs in the near-term.
Is Borqs Technologies a Good Chinese Stock to Buy on the Dip?
China-based Borqs Technologies’ (BRQS) shares popped in February as investors bet on their hopes regarding its forthcoming 5G industrial park project. However, there’s a niggling question hanging around this name: are concerns related to its delisting in the United States a thing of the past? Let’s find out.
Bristol Myers Squibb is a Good Dividend Stock: Should You Buy?
Bristol-Myers Squibb (BMY) is on a roll. The company has historically generated significant and consistent revenue growth. It has also paid dividends each quarter for more than three decades. And because its stock is undervalued at its current price level, we think it could be wise to bet on the stock now, amid the current market volatility. Read on.
Is Royalty Pharma a Biotech Stock Worth Buying?
Royalty Pharma (RPRX), which is known for its unique business in which it buys biopharmaceutical royalties, had an impressive market debut in June 2020. However, its share price has fluctuated considerably since. So, let’s dig deeper into the company’s prospects and learn if it is wise to bet on the stock now.
TPI Composites: Should You Buy the Dip in this Clean Energy Stock?
Shares of TPI Composites (TPIC) have retreated significantly since hitting their all-time high of $81.36 on February 16 due to the company’s less than promising financial results and a broader market sell-off. So, the question is can TPIC’s long-term contracts help it stay afloat during these difficult times? Let’s find out.
After Rallying 35% in 2021, Will Gap Stock Continue to Move Higher?
Gap (GPS) has made an impressive recovery from its pandemic lows by relying on its online sales growth and high demand for its Athleta and Old Navy brands. Let’s evaluate if the stock can rally more after hitting its all-time high of $32.95 on March 15, 2021.